Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

Completed · Phase 2 · Has a placebo group

Conditions studied: Liver Transplant

In brief

This study is being done to determine if patients receiving (iNO) will have increased liver function and less damage from IR than patients who do not receive (iNO).

Key facts

Study ID

NCT01172691

Run by

Baylor Research Institute

People needed

23

Starts

2010-07-01

Expected to finish

2014-01-22

Last updated by the study team

2026-01-28

Who can join

Age: 17 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Liver Transplant

You may not qualify if…

• Living donor transplants

Where it is running

• Baylor Univsersity Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.